Ireland
RediCare Control is a digitally delivered service designed to effectively treat and prevent chronic conditions. The company focuses on treating and preventing chronic conditions such as High Blood Pressure, Pre-Diabetes, Type 2 Diabetes, High Cholesterol, Polycystic Ovary Syndrome (PCOS), Non-Alcoholic Fatty Liver Disease (NAFLD), Obesity, and Overweight conditions.
Founded in 2016 and headquartered in Ireland, RediCare Control operates within the Health Care and Platforms industries. The company collaborates with multiple primary care networks across the UK, aiming to redefine the approach to scaling the treatment of chronic diseases and subsequently leading to healthier patient populations and reduced demand in general practice.
Notably, over 200 companies in the UK and Ireland trust RediCare ControlDTX to provide health screening and chronic condition treatment for their employees. This trust has resulted in quantifiable health improvements in employee populations.
Currently, there is no public information available regarding the last investment or the investors involved in RediCare Control's latest funding round.
